NPM1 and acute myeloid leukemia: Several studies, including ours, clearly demonstrated that the frequency of NPM1 gene mutations is significantly higher in AML patients with a normal karyotype [22], despite results being heterogeneous and varying from 38.1% to 63.8% [22,23].